<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Skolchart Pongmaneratanakul และผู้แต่งคนอื่นๆ. (2016) Association of RRM1, ERCC1 and CTR1 polymorphisms with response and toxicities of gemcitabine-platinum chemotherapy in patients with unresectable cholangiocarcinoma. Chulalongkorn University:ม.ป.ท.</APA><Chicago>Skolchart Pongmaneratanakul และผู้แต่งคนอื่นๆ. 2016. Association of RRM1, ERCC1 and CTR1 polymorphisms with response and toxicities of gemcitabine-platinum chemotherapy in patients with unresectable cholangiocarcinoma. ม.ป.ท.:Chulalongkorn University;</Chicago><MLA>Skolchart Pongmaneratanakul และผู้แต่งคนอื่นๆ.  Association of RRM1, ERCC1 and CTR1 polymorphisms with response and toxicities of gemcitabine-platinum chemotherapy in patients with unresectable cholangiocarcinoma.  ม.ป.ท.:Chulalongkorn University, 2016. Print.</MLA></bibliography></xml>
